EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
Cited by 68
Related Papers
miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene
|Journal of Experimental & Clinical Cancer Research|2018|92
miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3
|International Journal of Molecular Medicine|2018|60
Natural Plant Extract Tubeimoside I Promotes Apoptosis-Mediated Cell Death in Cultured Human Hepatoma (HepG2) Cells
|Biological and Pharmaceutical Bulletin|2011|41
HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer
|Journal of Cancer|2021|37
EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation
|BMC Pulmonary Medicine|2021|24